Combined HSP90 and kinase inhibitor therapy: Insights from The Cancer Genome Atlas.
about
HSP90 as a novel molecular target in non-small-cell lung cancerSigma1 Pharmacology in the Context of Cancer.Inhibition of heat shock protein 90 exerts an antitumour effect in angiosarcoma: involvement of the vascular endothelial growth factor signalling pathway.Adapting to stress - chaperome networks in cancer.
P2860
Combined HSP90 and kinase inhibitor therapy: Insights from The Cancer Genome Atlas.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Combined HSP90 and kinase inhibitor therapy: Insights from The Cancer Genome Atlas.
@ast
Combined HSP90 and kinase inhibitor therapy: Insights from The Cancer Genome Atlas.
@en
type
label
Combined HSP90 and kinase inhibitor therapy: Insights from The Cancer Genome Atlas.
@ast
Combined HSP90 and kinase inhibitor therapy: Insights from The Cancer Genome Atlas.
@en
prefLabel
Combined HSP90 and kinase inhibitor therapy: Insights from The Cancer Genome Atlas.
@ast
Combined HSP90 and kinase inhibitor therapy: Insights from The Cancer Genome Atlas.
@en
P2093
P2860
P1476
Combined HSP90 and kinase inhibitor therapy: Insights from The Cancer Genome Atlas
@en
P2093
Alok Mishra
Brad Scroggins
Harvey Schwartz
Kristin Beebe
Len Neckers
Thomas Prince
Toshiki Kijima
P2860
P2888
P304
P356
10.1007/S12192-015-0604-1
P577
2015-06-13T00:00:00Z